Literature DB >> 235232

Drug spotlight program: antacids and anticholinergic drugs.

A Littman, B H Pine.   

Abstract

Controlled clinical trials have provided some useful evidence of the effectiveness or lack of effectiveness of antacids and anticholinergic drugs. However, few such trials are free of serious methodologic or clinical criticism, and the use of these agents cannot be defined with any degree of scientific certainty. Their principal uses still focus on reduction of gastric acid content, and their best use requires individualization for each patient. With anticholinergic drugs there is little if any pharmacologic effect without some side-effects, and dose adjustment may be more important than the choice among the many drugs considered effective. Some new antacids offer better neutralization than old ones, but are at least as likely to affect colonic function. Although toxicity, side-effects, and interactions with other drugs are minimal, they should be watched for.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 235232     DOI: 10.7326/0003-4819-82-4-544

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  7 in total

Review 1.  Treatment of uncomplicated gastric ulcer.

Authors:  W D Davis
Journal:  Am J Dig Dis       Date:  1976-02

2.  Gastric ulcer: effect of healing on gastric acid secretion and fasting serum gastrin levels.

Authors:  J M Boyle; A L Hurwitz; R S Jones; C M Mansbach
Journal:  Am J Dig Dis       Date:  1977-12

3.  Inhibition of nocturnal acid secretion in duodenal ulcer patients by an H-2 histamine antagonist-cimetidine. A controlled double-blind investigation.

Authors:  D Hollander; Z Hossain; A M Sufi
Journal:  Am J Dig Dis       Date:  1976-05

4.  Which antacid?

Authors:  D W Piper; J Kang
Journal:  Drugs       Date:  1979-02       Impact factor: 9.546

Review 5.  Antacids revisited: a review of their clinical pharmacology and recommended therapeutic use.

Authors:  P N Maton; M E Burton
Journal:  Drugs       Date:  1999-06       Impact factor: 9.546

6.  Acid neutralization capacity of Canadian antacid formulations.

Authors:  M E MacCara; F J Nugent; J B Garner
Journal:  Can Med Assoc J       Date:  1985-03-01       Impact factor: 8.262

Review 7.  Pirenzepine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in peptic ulcer disease and other allied diseases.

Authors:  A A Carmine; R N Brogden
Journal:  Drugs       Date:  1985-08       Impact factor: 9.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.